# Protective Effects of Saxagliptin (And Vitamin D3) on β Cell Function in Adult-onset Latent Autoimmune Diabetes

> **NCT02407899** · PHASE4 · COMPLETED · sponsor: **Second Xiangya Hospital of Central South University** · enrollment: 300 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Saxagliptin
- **DRUG:** Vitamin D3
- **DRUG:** Insulin
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT02407899
- **Lead sponsor:** Second Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-31
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2021-04-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02407899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02407899, "Protective Effects of Saxagliptin (And Vitamin D3) on β Cell Function in Adult-onset Latent Autoimmune Diabetes". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02407899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*